Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PFE vs MRNA✓SelectedUSD · MRNAPFE vs MRNA performance historyLatest closeAs of-0.51%11/20
Stock and ETF performance explorer

PFE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-29.9%
MRNA return
-27.3%
Excess return
-2.6%
Maximum drawdown
-59.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.5%-2.2%+1.7%-0.4%
7D-5.2%-12.7%+7.5%-4.3%
30D-6.9%-20.7%+13.8%-5.7%
3M0.0%+46.3%-46.2%-3.0%
6M+9.7%+305.2%-295.6%-8.2%
YTD+17.4%+561.2%-543.8%-10.2%
1Y+19.8%+772.1%-752.3%-12.4%
3Y+11.0%+147.0%-136.0%-7.6%
All-29.9%-27.3%-2.6%-33.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling